These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7477049)
1. Comparison of lacI and lacZ transgenic mouse mutation assays: an EU-sponsored interlaboratory study. Tinwell H; Liegibel U; Krebs O; Schmezer P; Favor J; Ashby J Mutat Res; 1995 Oct; 335(2):185-90. PubMed ID: 7477049 [TBL] [Abstract][Full Text] [Related]
2. Response of the Muta mouse lacZ/galE- transgenic mutation assay to DMN: comparisons with the corresponding Big Blue (lacI) responses. Tinwell H; Lefevre PA; Ashby J Mutat Res; 1994 May; 307(1):169-73. PubMed ID: 7513794 [TBL] [Abstract][Full Text] [Related]
3. Long-term mutagenicity studies with chloroform and dimethylnitrosamine in female lacI transgenic B6C3F1 mice. Butterworth BE; Templin MV; Constan AA; Sprankle CS; Wong BA; Pluta LJ; Everitt JI; Recio L Environ Mol Mutagen; 1998; 31(3):248-56. PubMed ID: 9585263 [TBL] [Abstract][Full Text] [Related]
4. Use of transgenic mouse lacI/Z mutation assays in genetic toxicology. Ashby J; Tinwell H Mutagenesis; 1994 May; 9(3):179-81. PubMed ID: 7934956 [TBL] [Abstract][Full Text] [Related]
5. Organ variation in the mutagenicity of dimethylnitrosamine in Big Blue mice. Suzuki T; Itoh T; Hayashi M; Nishikawa Y; Ikezaki S; Furukawa F; Takahashi M; Sofuni T Environ Mol Mutagen; 1996; 28(4):348-53. PubMed ID: 8991063 [TBL] [Abstract][Full Text] [Related]
6. Mutant frequencies and mutation spectra of dimethylnitrosamine (DMN) at the lacI and cII loci in the livers of Big Blue transgenic mice. Shane BS; Smith-Dunn DL; de Boer JG; Glickman BW; Cunningham ML Mutat Res; 2000 Sep; 452(2):197-210. PubMed ID: 11024479 [TBL] [Abstract][Full Text] [Related]
7. Initial experiences and future directions for transgenic mouse mutation assays. Suzuki T; Hayashi M; Sofuni T Mutat Res; 1994 Jun; 307(2):489-94. PubMed ID: 7514722 [TBL] [Abstract][Full Text] [Related]
8. Comparison of mutant frequencies at the transgenic lambda LacI and cII/cI loci in control and ENU-treated Big Blue mice. Zimmer DM; Harbach PR; Mattes WB; Aaron CS Environ Mol Mutagen; 1999; 33(3):249-56. PubMed ID: 10334627 [TBL] [Abstract][Full Text] [Related]
9. Mutation studies with dimethyl nitrosamine in young and old lac I transgenic mice. Tinwell H; Lefevre PA; Ashby J Mutat Res; 1994 Jun; 307(2):501-8. PubMed ID: 7514724 [TBL] [Abstract][Full Text] [Related]
10. Reporter gene transgenic mice as a tool for analyzing the molecular mechanisms underlying experimental carcinogenesis. Nishikawa A; Suzuki T; Masumura K; Furukawa F; Miyauchi M; Nakamura H; Son HY; Nohmi T; Hayashi M; Hirose M J Exp Clin Cancer Res; 2001 Mar; 20(1):111-5. PubMed ID: 11370817 [TBL] [Abstract][Full Text] [Related]
11. Interlaboratory comparison: liver spontaneous mutant frequency from lambda/lacI transgenic mice (Big Blue) (II). Young RR; Rogers BJ; Provost GS; Short JM; Putman DL Mutat Res; 1995 Mar; 327(1-2):67-73. PubMed ID: 7870100 [TBL] [Abstract][Full Text] [Related]
12. A preliminary evaluation of the performance of the Muta Mouse (lacZ) and Big Blue (lacI) transgenic mouse mutation assays. Morrison V; Ashby J Mutagenesis; 1994 Jul; 9(4):367-75. PubMed ID: 7968580 [TBL] [Abstract][Full Text] [Related]
13. Comparative study on organ-specificity of tumorigenicity, mutagenicity and cell proliferative activity induced by dimethylnitrosamine in Big Blue mice. Nishikawa A; Furukawa F; Kasahara K; Lee IS; Suzuki T; Hayashi M; Sofuni T; Takahashi M Cancer Lett; 1997 Aug; 117(2):143-7. PubMed ID: 9377541 [TBL] [Abstract][Full Text] [Related]
14. Consideration of the liver of embryonic lacZ transgenic mice as an analogue of the mouse coat colour spot test: preliminary data and technical problems. Morrison V; Tinwell H; Ashby J Mutat Res; 1995 Jul; 329(2):107-12. PubMed ID: 7603492 [TBL] [Abstract][Full Text] [Related]
15. In vivo mutagenesis by the hepatocarcinogen quinoline in the lacZ transgenic mouse: evidence for its in vivo genotoxicity. Suzuki T; Miyata Y; Saeki K; Kawazoe Y; Hayashi M; Sofuni T Mutat Res; 1998 Jan; 412(2):161-6. PubMed ID: 9539970 [TBL] [Abstract][Full Text] [Related]
16. Organ variation in the mutagenicity of ethylnitrosourea in Muta mouse: results of the collaborative study on the transgenic mutation assay by JEMS/MMS. The Collaborative Study Group for the Transgenic Mouse Mutation Assay Mammalian Mutagenesis Study Group of the Environmental Mutagen Society of Japan. Environ Mol Mutagen; 1996; 28(4):363-75. PubMed ID: 8991065 [TBL] [Abstract][Full Text] [Related]
17. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene. Hayward JJ; Shane BS; Tindall KR; Cunningham ML Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147 [TBL] [Abstract][Full Text] [Related]
18. The use of shuttle vectors for mutation analysis in transgenic mice and rats. Dycaico MJ; Provost GS; Kretz PL; Ransom SL; Moores JC; Short JM Mutat Res; 1994 Jun; 307(2):461-78. PubMed ID: 7514720 [TBL] [Abstract][Full Text] [Related]
19. Hepatic lacI and cII mutation in transgenic (lambdaLIZ) rats treated with dimethylnitrosamine. Gollapudi BB; Jackson KM; Stott WT Mutat Res; 1998 Nov; 419(1-3):131-5. PubMed ID: 9804924 [TBL] [Abstract][Full Text] [Related]
20. The lacI transgenic mouse mutagenicity assay: quantitative evaluation in comparison to tests for carcinogenicity and cytogenetic damage in vivo. Shephard SE; Lutz WK; Schlatter C Mutat Res; 1994 Apr; 306(2):119-28. PubMed ID: 7512210 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]